<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9212404</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21262</journal-id>
<journal-id journal-id-type="nlm-ta">Pharmacoeconomics</journal-id>
<journal-id journal-id-type="iso-abbrev">Pharmacoeconomics</journal-id>
<journal-title-group>
<journal-title>PharmacoEconomics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1170-7690</issn>
<issn pub-type="epub">1179-2027</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26446859</article-id>
<article-id pub-id-type="pmc">4761298</article-id>
<article-id pub-id-type="doi">10.1007/s40273-015-0331-6</article-id>
<article-id pub-id-type="manuscript">NIHMS729184</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>National Database for Autism Research (NDAR): Big Data Opportunities for Health Services Research and Health Technology Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Payakachat</surname>
<given-names>Nalin</given-names>
</name>
<email>npayakachat@uams.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tilford</surname>
<given-names>J. Mick</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ungar</surname>
<given-names>Wendy J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 522, Little Rock, AR 72205, USA</aff>
<aff id="A2"><label>2</label>Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR, USA</aff>
<aff id="A3"><label>3</label>Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada</aff>
<aff id="A4"><label>4</label>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada</aff>
<author-notes>
<fn fn-type="conflict" id="FN1">
<p><bold>Compliance with Ethical Standards</bold>: <bold>Conflict of interest</bold> Nalin Payakachat and J. Mick Tilford serve on a grant that seeks to identify novel uses in the NDAR. Wendy J. Ungar declares no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>34</volume>
<issue>2</issue>
<fpage>127</fpage>
<lpage>138</lpage>
<!--elocation-id from pubmed: 10.1007/s40273-015-0331-6-->
<abstract>
<p id="P1">The National Database for Autism Research (NDAR) is a US National Institutes of Health (NIH)-funded research data repository created by integrating heterogeneous datasets through data sharing agreements between autism researchers and the NIH. To date, NDAR is considered the largest neuroscience and genomic data repository for autism research. In addition to biomedical data, NDAR contains a large collection of clinical and behavioral assessments and health outcomes from novel interventions. Importantly, NDAR has a global unique patient identifier that can be linked to aggregated individual-level data for hypothesis generation and testing, and for replicating research findings. As such, NDAR promotes collaboration and maximizes public investment in the original data collection. As screening and diagnostic technologies as well as interventions for children with autism are expensive, health services research (HSR) and health technology assessment (HTA) are needed to generate more evidence to facilitate implementation when warranted. This article describes NDAR and explains its value to health services researchers and decision scientists interested in autism and other mental health conditions. We provide a description of the scope and structure of NDAR and illustrate how data are likely to grow over time and become available for HSR and HTA.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>